摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2'-脱氧三氮唑核苷 | 40372-06-3

中文名称
2'-脱氧三氮唑核苷
中文别名
——
英文名称
1-(2'-deoxy-β-D-ribofuranosyl)-1H-1,2,4-triazole-3-carboxamide
英文别名
2'-deoxyribavirin;1-(β-D-erythro-2-deoxy-pentofuranoyl)-1H-[1,2,4]triazole-3-carboxylic acid amide;1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide
2'-脱氧三氮唑核苷化学式
CAS
40372-06-3
化学式
C8H12N4O4
mdl
——
分子量
228.208
InChiKey
GODSJHAJEWFDAD-KVQBGUIXSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    112-113 °C
  • 沸点:
    587.7±60.0 °C(Predicted)
  • 密度:
    1.90±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    -0.9
  • 重原子数:
    16
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.62
  • 拓扑面积:
    124
  • 氢给体数:
    3
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2'-脱氧三氮唑核苷 生成 [(2R,3S,5R)-5-(3-carbamoyl-1,2,4-triazol-1-yl)-3-hydroxyoxolan-2-yl]methyl 4-methylbenzoate
    参考文献:
    名称:
    SANGHVI, YOGESH S.;HANNA, NAEEM B.;LARSON, STEVEN B.;ROBINS, ROLAND K.;RE+, NUCLEOSIDES AND NUCLEOTIDES, 6,(1987) N 4, 761-774
    摘要:
    DOI:
  • 作为产物:
    参考文献:
    名称:
    Imidazole-4-Carboxamide and 1,2,4-Triazole-3-Carboxamide Deoxynucleotides as Simplified DNA Building Blocks with Ambiguous Pairing Capacity
    摘要:
    2'-Deoxynucleosides of imidazole-4 (or 1,2,4-triazole-3)-carboxamide, ethyl imidazole-4 (or 1,2,4 triazole-3)-carboxylate were synthesized by enzymatic glycosylation using N-deoxyribosyltransferase from a lactobacterium. The base:pairing properties of Y and V when placed opposite the natural DNA bases as well as their self were evaluated by thermal denaturation experiments. DNA templates containing imidazole-4-carboxamide base were used in elongation reaction catalysed by Klenow fragment.
    DOI:
    10.1080/07328319808004740
点击查看最新优质反应信息

文献信息

  • A Combination Chemical and Enzymatic Approach for the Preparation of Azole Carboxamide Nucleoside Triphosphate
    作者:Weidong Wu、Donald E. Bergstrom、V. Jo Davisson
    DOI:10.1021/jo020745i
    日期:2003.5.1
    biochemical tools. Many of the standard methods for nucleoside triphosphate synthesis fail in the cases of nonpurine and nonpyrimidine nucleosides. An efficient preparation of the 5'-O-tosylates for both the deoxy- and ribonucleosides enabled preparation of the diphosphate esters by displacement with tris(tetra-n-butylammonium) pyrophosphate. Enzymatic synthesis of the azole carboxamide deoxyribonucleoside
    DNA和RNA聚合酶的替代底物提供了一组重要的生化工具。在非嘌呤和非嘧啶核苷的情况下,许多标准的三磷酸核苷合成方法都失败了。有效地制备脱氧核糖核苷和核糖核苷的5'-O-甲苯磺酸酯能够通过用焦磷酸三(四正丁基铵)置换来制备二磷酸酯。ATP的磷酸供体,二磷酸核苷激酶作为催化剂的酶合成吡咯酰胺脱氧核糖核苷三磷酸是基于磷酸烯醇丙酮酸(PEP)和丙酮酸激酶作为ATP再生系统。核糖核苷三磷酸的合成需要PEP作为磷酸供体,丙酮酸激酶作为催化剂。开发了基于硼酸酯亲和力凝胶的优化纯化程序以产生高度纯化的三磷酸核苷。本文概述的策略为制备5'-三磷酸核苷提供了一种新的有效方法,可能适用于多种碱基和糖修饰的核苷类似物。
  • <i>Aeromonas hydrophila</i>strains as biocatalysts for transglycosylation
    作者:Matías Nóbile、Marco Terreni、Elizabeth Lewkowicz、Adolfo M. Iribarren
    DOI:10.3109/10242422.2010.538949
    日期:2010.12
    Microbial transglycosylation is useful as a green alternative in the preparation of purine nucleosides and analogues, especially for those that display pharmacological activities. In a search for new transglycosylation biocatalysts, two Aeromonas hydrophila strains were selected. The substrate specificity of both micro-organisms was studied and, as a result, several nucleoside analogues have been prepared. Among them, ribavirin, a broad spectrum antiviral, and the well-known anti HIV didanosine, were prepared, in 77 and 62% yield using A. hydrophila CECT 4226 and A. hydrophila CECT 4221, respectively. In order to scale-up the processes, the reaction conditions, product purification and biocatalyst preparation were analyzed and optimized.
  • Development of a nanostabilized biocatalyst using an extremophilic microorganism for ribavirin biosynthesis
    作者:Eliana C. De Benedetti、Cintia W. Rivero、Jorge A. Trelles
    DOI:10.1016/j.molcatb.2015.08.006
    日期:2015.11
    Ribavirin is a guanosine analogue commonly used as an antiviral compound for the treatment of Hepatitis C virus (HCV) infection. The biosynthesis of this compound using Geobacillus kaustophilus ATCC 8005 as biocatalyst is herein reported. This extremophilic microorganism has been successfully entrapped in an agarose matrix supplemented with bentonite, which was defined as bionanocomposite. This immobilized biocatalyst was stable for more than 580 h without activity loss, significantly improving operational stability and mechanical properties over the conventional agarose matrix.Furthermore, a packed-bed bioreactor for bioprocess scale-up was designed, which was able to produce 370 mg L-1 of ribavirin. In conclusion, a smooth, inexpensive and environmentally friendly method to obtain ribavirin was developed in this study. (C) 2015 Elsevier B.V. All rights reserved.
  • In Search of New Inhibitors of HIV-1 Replication: Synthesis and Study of 1-(2′-Deoxy-β-D-Ribofuranosyl)-1,2,4-Triazole-3-Carboxamide as a Selective Viral Mutagenic Agent
    作者:V. Vivet-Boudou、J.-C. Paillart、A. Burger、R. Marquet
    DOI:10.1080/15257770701490902
    日期:2007.11.26
    With the emergence of HIV strains resistant or cross-resistant to nearly all antiretroviral regimen, novel therapy approaches have to be considered. As a part of our current work on viral mutagenic compounds, we prepared 1-(2' -deoxy-beta-D-ribofuranosyl)-1,2,4-triazole-3-carboxamide (2' -deoxy-ribavirin) and its 5' -triphosphate derivative. The nucleoside mutagenic activity was evaluated on HIV-1 NL4-3 in CEMx174 cell culture. After 2.5 months, no reduction on HIV-1 viability was observed. On the other hand, in vitro experiments with purified HIV-1 RT demonstrated that the triphosphate analog can be incorporated opposite to several natural nucleosides.
  • USRE29835E
    申请人:——
    公开号:USRE29835E
    公开(公告)日:1978-11-14
查看更多

同类化合物

利巴韦林杂质G 利巴韦林杂质E 利巴韦林杂质B 利巴韦林 利巴韦林 三氮唑核苷脒盐酸盐 三氮唑核苷羧酸 三氮唑核苷5'-氨基磺酸 三氮唑核苷-5'-磷酸酯 三氮唑核苷 5'-二磷酸酯 三氮唑核苷 5'-三磷酸酯 三氮唑核苷 2',3',5'-三乙酸酯 三乙酰利巴韦林甲酯 [5-(3-氨基-1,2,4-三唑-1-基)-3,4-二苯甲酰氧基-四氢呋喃-2-基]甲基苯甲酸酯 [(2R,3S,4R,5R)-5-(3-硫代氨基甲酰-1,2,4-三唑-1-基)-3,4-二羟基四氢呋喃-2-基]甲基氨基磺酸 [(2R,3S,4R,5R)-5-(3-氨基羰基-1,2,4-三唑-1-基)-3,4-二羟基-四氢呋喃-2-基]甲基二氢磷酸酯与N,N-二乙基乙胺的化合物 5-氨基-1-[(2R,3R,4S,5R)-3,4-二羟基-5-(羟基甲基)四氢呋喃-2-基]-1,2,4-三唑-3-甲脒盐酸盐 5'-O-吡喃葡萄糖基三氮唑核苷 5'-O-吡喃半乳糖基三氮唑核苷 3-氰基-1-(2,3,5-三-O-乙酰基-beta-D-呋喃核糖基)-1,2,4-三唑 2’,3’-异亚丙基三氮唑核苷 2',3'-异亚丙基α-利巴韦林 2'-脱氧三氮唑核苷 1-Β-D-呋喃核糖基-1H-1,2,4-三氮唑-3-羧酸甲酯 1-[2,3-O-异亚丙基-beta-D-呋喃核糖基]-1,2,4-三唑-3-羧酸甲酯 1-[(2S,3S,4S,5S)-3,4-二羟基-5-(羟基甲基)四氢呋喃-2-基]-1,2,4-三唑-3-甲酰胺 1-[(2R,3R,4R,5R)-3,4-二丁氧基-5-(丁氧基甲基)四氢呋喃-2-基]-1,2,4-三唑-3-甲酰胺 1-(2-C-甲基-BETA-D-呋喃核糖基)-1H-1,2,4-三唑-3-甲酰胺 (2R,3S,4R,5R)-2-(羟基甲基)-5-[3-(甲氧基亚胺甲酰基)-1,2,4-三唑-1-基]四氢呋喃-3,4-二醇 (2R,3R,4S,5R)-2-[3-(乙氧基亚胺甲酰基)-1,2,4-三唑-1-基]-5-(羟基甲基)四氢呋喃-3,4-二醇 N1-(2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)-C4-(coumarin-7-oxymethyl)-1,2,3-triazole 4,5-dibromo-1-(5-O-sulfamoyl-β-D-ribofuranosyl)triazole (2R,3R,4S,5R)-3'-(2-fluorophenyl)-5-(hydroxymethyl)-4,5-dihydro-3H,4'H,6'H-spiro[furan-2,7'-[1,2,3]triazolo[5,1-c][1,4]oxazine]-3,4-diol 4-((1-(β-D-ribofuranos-1-yl)-1,2,3-triazol-4-yl)methoxy)-2-phenylquinazoline ribavirin-5’-O-bis(benzoxy-L-alaninyl)phoshate 1-(5-deoxy-5-N-phosphonomethylamino-β-D-ribofuranosyl)-1,2,4-triazole-3-carboxamide (2R,3R,4S,5R)-3'-(4-chlorophenyl)-5-(hydroxymethyl)-4,5-dihydro-3H,4'H,6'H-spiro[furan-2,7'-[1,2,3]triazolo[5,1-c][1,4]oxazine]-3,4-diol 1-(4'-azido-2'-deoxy-2'-fluoro-β-D-arabinofuranosyl)-4-cyclopropyl-[1,2,3]-triazole 1-(5-O-thiophosphoryl-β-D-ribofuranosyl)-1,2,4-triazole-3-carboxamide 5-[2-(4-chlorophenyl)ethynyl]-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-[2-(1-methylimidazol-4-yl)ethynyl]-1,2,4-triazole-3-carboxamide 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-[2-[2-(trifluoromethyl)phenyl]ethynyl]-1,2,4-triazole-3-carboxamide 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-[2-(4-methylphenyl)ethynyl]-1,2,4-triazole-3-carboxamide 5-(4-trifluoromethylphenylethynyl)-1-(2,3,5-tri-hydroxy-β-D-ribofuranosyl)-1H-[1,2,4]triazole-3-carboxylic acid amide 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(2-phenylethynyl)-1,2,4-triazole-3-carboxamide 5-(5-chloropent-1-ynyl)-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide 5-(3-trifluoromethyl-phenylethynyl)-1-(2,3,5-tri-hydroxy-β-D-ribofuranosyl)-1H-[1,2,4]triazole-3-carboxylic acid amide 5-(thiophen-3-ylethynyl)-1-(2,3,5-tri-hydroxy-β-D-ribofuranosyl)-1H-[1,2,4]triazole-3-carboxylic acid amide 5-(4-methoxyphenylethynyl)-1-(2,3,5-tri-hydroxy-β-D-ribofuranosyl)-1H-[1,2,4]triazole-3-carboxylic acid amide 4-tetradecyloxymethyl-1-(β-D-arabinofuranosyl)-1,2,3-triazole